SurvNet: A low-complexity convolutional neural network for survival time classification of patients with glioblastoma
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.SurvNet, a deep learning model using magnetic resonance imaging (MRI), accurately predicts brain tumor survival. Combining segmented data and four MRI modalities, it achieved 82.4% accuracy, outperforming other models.
Area Of Science
- Neuro-oncology
- Medical Imaging
- Artificial Intelligence
Background
- Malignant primary brain tumors, especially Grade 4 glioma, have poor prognoses with limited survival.
- Accurate prediction of overall survival time is crucial for clinical applications.
- Automated analysis of magnetic resonance imaging (MRI) offers insights into brain tumor prognosis.
Purpose Of The Study
- To develop SurvNet, a deep learning model for classifying brain tumor patient survival into long-term and short-term cohorts.
- To evaluate the performance of SurvNet using diverse MRI modalities and segmented tumor data.
- To compare SurvNet's predictive accuracy against established deep learning models.
Main Methods
- Proposed SurvNet, a low-complexity convolutional neural network architecture.
- Integrated diverse MRI modalities (e.g., T1) as input for enhanced feature extraction.
- Compared SurvNet with Inception V3, VGG 16, and ensemble CNN models on pre-operative MRI datasets.
- Analyzed the impact of segmented brain tumors and training data on system performance.
Main Results
- SurvNet with T1 MRI achieved 62.7% accuracy, surpassing Inception V3 (52.9%), VGG 16 (58.5%), and ensemble CNN (54.9%).
- Increasing MRI modalities improved SurvNet's accuracy to 76.5% with four modalities.
- Combining segmented data and four MRI modalities resulted in the highest accuracy of 82.4%.
Conclusions
- SurvNet demonstrates superior performance in classifying brain tumor survival compared to other models.
- Multiparametric MRI modalities enhance SurvNet's ability to learn image features and improve classification accuracy.
- The complete scenario (segmented data and four MRI modalities) yielded the best accuracy, validating the utility of segmentation in survival prediction.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...